Loading...
 

INSTRUCTIONS FOR AUTHORS

PNEUMON is a peer reviewed journal,published quarterly as the official scientific journal of the Hellenic Thoracic Society. The Journal publishes original papers of internationalinterest on laboratory and clinical research that are pertinent to lung biologyand disease. Clinical and experimental work dealing with the whole field ofrespiratory medicine, including allied health, cell and molecular biology,epidemiology, immunology, pathology, pharmacology, physiology, intensive andcritical care, pediatric respiratory medicine and thoracic surgery will beconsidered for publication.

Articles published in PNEUMON address topics related to pneumonology and critical care medicine in the following categories: (1) Editorials, (2) Reviews, (3) Basicand Clinical Research Studies, (4) Case Reports, (5) Special Articles, and (6) Letters to the Editor. Details on the length and number of references for eachtype of publication can be found at the end of this text.

Editorials, reviews and special articles are published following invitation by the Editorial Board. The Editorial Board reserves the right of publishing othertypes of papers as well. Papers submitted for publication will not be returned, irrespective of whether they are published or not. Published papers are aliterary property of both the authors and the journal and their publication, in part or in whole, without written permission of the Editorial Board is prohibited.

Index

 

Requirements and Ethics of Publication

Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance has been or will be publishedor submitted elsewhere. Copies of any closely related manuscripts must be submitted along with the manuscript. PNEUMON discourages the submission of more than one article dealing with related aspects of the same study. Authors are advised to follow the "Uniform Requirements for Manuscripts Submittedto Biomedical Journals," published by the International Committee of Medical Journal Editors (http://www.icmje.org).

Credit for Authorship

Following the recommendations of the International Committee of Medical Journal Editors, "author" is a person who has participated sufficiently in the work to take public responsibility for portions of the content. Specifically, an author is a person who (1) has made substantial contributions to conception and design, oracquisition of data, or analysis and interpretation of data; (2) has drafted the submitted article or revised it critically for important intellectualcontent, and (3) has provided final approval of the version to be published. Any person who does not meet all three of the listed criteria does not qualify as an author and should not be designated as an author. Importantly, any change in authorship after submission must be approved in writing by all authors.

Human and Animal Study Guidelines

PNEUMON endorses recommendations concerning human research described in the Declaration of Helsinki (World Medical Association Declaration of Helsinki). Recommendations guiding physicians in biomedical research involving human subjects. JAMA1997;277:925-926. 

Available at: http://www.wma.net/e/policy/b3.htm). Manuscripts that do not conform to these recommendations may not be considered for publication. Manuscripts reporting human research must state within the text that the study has been approved by the Review Board or Ethics Committee of their Institution and that written informed consent was obtained from all subjects or their surrogates. Additionally, authors must omit form their manuscripts any identifying details regarding patients or study participants. Patient details (e.g. photographs) may be included in a manuscript only if they are essential for scientific purposes and, in that case, authors must provide written informed consent from the patient, parent or guardian, and this must be clearly stated in the manuscript.

Animal studies must follow internationally recognized guidelines, e.g. the US national Research Council guidelines (Institute of Laboratory Animal Resources, NationalResearch Council. Guide for the care and use of laboratory animals. Washington,DC: National Academy Press, 1996. Available at: http://books.nap.edu/catalog.php?record_id=5140; accessed November 9, 2008). Humane care for all animals is required, and details should be provided. 

Reporting Clinical Trials

PNEUMON requires that investigators register their clinical trials (other than phase 1trials) in a public trials registry (e.g. http://www.clicaltrials.gov). According to the WHO definition, a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." The name of the registry and the registration number should be clearly stated in the last paragraph of the Abstract and in the Materials and Methods section of the manuscript. Purely observational studies (those in which the assignment of the medical intervention is not the discretion of the investigator) do not require registration. Further information on this subject can be found on the International Committee of Medical Journal Editors website (http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html).

In manuscripts that report data from randomized clinical trials, authors should follow the flow diagram and/or checklist of the Consolidated Standards of Reporting Trials (CONSORT) format and provide all the information required (available at: http://www.consort-statement.org; accessed November 9, 2008).

Reporting Other Types of Studies

PNEUMON suggests that authors follow the international standards for other types of publications. For example, (1) meta-analyses and systematic reviews should conform to the QUOROM requirements (Moher D, et al. Lancet 1999; 356:1996-2000); (2) meta-analyses of observational studies in epidemiology should conform to the MOOSE requirements (Stroup DF, et al. JAMA 2000; 2008-2012); (3) studies of diagnostic accuracy should conform to the STARD statement (available at http://www.stard-statement.org; accessed November 9, 2008); and (4) observational studies in epidemiology should conform to the STROBE statement (von Elm E, et al. BMJ 2007;335;806-808).

Conflicts of Interest

A conflict of interest exists if authors or their institutions have financial or personal relationships with other people or organizations that might inappropriately affect, or might reasonably be thought by others to affect, the authors' judgment or actions. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted. Conflicts of interest should be clearly stated in the Title page of the manuscript. If there are no conflicts of interest, authors should state that. For further information on how to report conflicts of interest, authors may refer to "the Lancet's policy on conflicts of interest" (James A, Horton R. Lancet 2003; 361: 8-9) (http://www.icmje.org/conflicts-of-interest/).

Tobacco Policy

PNEUMON will not consider for publication manuscripts that have been supported in whole or in part or sponsored in any way by tobacco companies and associated institutes and organizations.

Publishing & Editorial Issues

Advertising

ThePNEUMON” journal is an outstanding place for companies in the respiratory field to promote themselves and their products through advertising. Please contact M. Stefanakis for detailed information: techn@hol.gr

Target area

The PNEUMON” journal targets a key professional market in the respiratory field, which has about 60 years' experience and extensive circulation.

Advertising policy and disclaimer

The aim of this policy is to ensure that the content of advertising in the PNEUMON” journal serves the best interests of the readers.

  • Advertisements must be legal, decent and accurate and must comply with the relevant laws and regulations.
  • Advertisements for products making therapeutic claims but without marketing authorization or CE marking (or local equivalent) should be submitted with all claims substantiated in full length research papers published in peer reviewed journals.
  • Readers should immediately be able to distinguish between advertising and editorial content.
  • “PNEUMON” journal accepts advertising for products and services that are of interest to users in their personal, as well as professional lives.
  • In line with the spirit of the policy on tobacco, “PNEUMON” journal does not accept advertising relating to tobacco products or to products and services from tobacco companies, their foundations, or their wholly owned subsidiaries.
  • “PNEUMON” journal does not allow advertising to influence editorial decisions.
  • Advertising is subject to editorial oversight. Advertising may be refused if it is judged by editors.

The advertiser shall be liable for the content of any of its advertisements published according to its instructions. The advertiser shall indemnify and hold harmless the “PNEUMON” journal against and from any and all claims, damages, liabilities, costs and expenses whatsoever, including reasonable counsel fees, arising from the content of any of its advertisements.

 

MANUSCRIPT SUBMISSION

All manuscripts and correspondence can be submitted by e-mail to the address pneumon@hts.org.gr. All submissions should include a Cover Letter and a single Manuscript file (including Body of Manuscript, References, Tables, Figure Legends, and Figures). Figures may be submitted also as separate files. All text should be double-spaced using 12-point type face (Arial or Times New Roman) and should be prepared in a word processing format (Microsoft Word preferred; an acceptable alternative would be PDF format). For the suggested length of publications please refer to Table 1 at the end of this document.

All authors must sign an agreement form (agreement form). The form must be scanned and send by e-mail at the time of the submission of the manuscript. 

Cover Letter

All manuscripts should be accompanied by a cover letter, signed by the corresponding author, clearly stating the following:

  1. Neither the article nor any part of its essential substance has been or will be published or submitted else where; if papers closely related to the submitted manuscript have been published or submitted for publication elsewhere, the authors should provide details.
  2. The clinical relevance of the work described and what it adds to the current literature.
  3. Potential significant conflicts of interest.
  4. The manuscript has been prepared according to the instructions for authors of PNEUMON and all authors have read and approved the text of the article.
  5. If accepted for publication, the copyright will be transferred to PNEUMON Journal.

Failure to provide a cover letter addressing each of the points above will result in the paper being returned to the author. The cover letter must be presented as a separate submission item.

Title page

The title page must contain the following information:

  1. The title of the manuscript (no more than 10 words). If it is necessary the title can include a sub-title
  2. The full name, institutions, city and country for all co-authors
  3. The full name, postal address, e-mail, telephone, and fax numbers of the corresponding author.
  4. Conflicts of interest of all authors.
  5. Potential funding or grant support of the work described.
  6. A running (short) title.
  7. The total number of words of the manuscript and the abstract.

Abstract

A structured abstract should be provided of up to 250 words. It should consist off our paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the most important results, and what the authors conclude from the results. Abbreviations should be avoided and, if used, they should be explained the first time mentioned.

Keywords

Up to 5 keywords that reflect the content of the manuscript should be provided. Authors should consult the Medical Subject Headings (MeSH) website (available at http://www.nlm.nih.gov/mesh/meshhome.html; accessed on November 9,2008).

Abbreviations

Please provide an alphabetical list of all abbreviations used in the manuscript on aseparate page. For clarity reasons, please use abbreviations sparingly. When abbreviations are used, they should be explained the first time they are mentioned in the text.

Body of Manuscript

The papershould include the following sections:

Introduction

The rationale for the study should be summarized and relevant background material outlined. The Introduction should not contain findings, methods used or conclusions.

Methods

Methods should be described in adequate detail to assure the reader as to how the results were obtained. In manuscripts reporting human research, the authors should report approval by the Review Board or Ethics Committee and that written informed consent was obtained from patients. The location (city, state,country) of a manufacturer listed in the text should be provided. Units should conform to SI conventions. Generic names of drugs should be used instead of trade names. Statistical methods should be meticulously described andreferenced.

Results

Results should be presented in a rational order in the text, tables and figures. The authors should avoid repetitive presentation of the same data in different forms, especially between the text and tables and figures. The Results should not include material appropriate to the Discussion.

Discussion

The discussion should start by presenting the new and most interesting data of thework in relation to any hypotheses made in the Introduction. Any unexpected or contradictory results should be explained or defended. For example, evaluationof methodology and the associations of new information to the existing knowledge in the topic should be discussed. Speculation should be kept to a minimum. The results must not be simply reiterated. New results should not appear in the Discussion. No specific reference to figures and tables should be included in the Discussion.

Acknowledgements

Acknowledge the persons who provided a true contribution and who endorse the data and conclusions. Acknowledge any funding sources.

References

Only published works may be cited as references. Manuscripts accepted but not yet published may be cited designating the accepting journal, followed by the term (in press), and copies of the in-press articles should be provided for reviewer inspection. References should be cited in the manuscript with superscript numerals in the order in which they appear in the text. The full list of references should be provided in numerical order on a separate page at the end of the text. References should include, in order, the following: authors, title, source, year of publication, volume, and inclusive page numbers. All authors should be listed if they are six or fewer; when they are seven or more, list the first three followed by "et al." Please abbreviate journalnames as in Index Medicus (available at http://www.nlm.nih.gov/tsd/serials/lji.html; accessed on November 9,2008).

The following are sample references:

  • Standard journal article: Bouros D, Antoniou KM, Light RW. Intrapleuralstreptokinase for pleural infection. BMJ2006; 332:133-4.
  • Books and other monographs: Siafakas NM, Anthonisen N, Georgopoulos D.Acute exacerbations of COPD. Marcel Dekker, NewYork, 2004.
  • Chapter in a book: Kyriakou D, Alexandrakis M, Bouros D. Pleural effusionsin blood diseases. In: Bouros D. (editor). Pleural Disease. Marcel Dekker, NewYork, 2004, pp. 621-638.

Numbered references to personal communications, unpublished data, or manuscripts either "in preparation" or "submitted for publication" are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.

Tables

Double-spacetables (including any footnotes) should be presented on separate pages, providing a title for each. Any abbreviations used in a Table should be defined in the Table's footnote.

Figures

Figures may be inserted in the text file or in a separate file (accepted formats are JPEG, TIFF and EPS). Legends for all figures should be included in the file with the text, on a separate page after the Tables, and should not appear on the actual figures. If photographs of patients are used, they should either not be identifiable or the photographs should be accompanied by written permission to use them.

Permission

The manuscript must be accompanied by copies of permission to reproduce previously published material (figures or tables); to use illustrations of, or reportsensitive personal information about, identifiable persons; and to name persons in the Acknowledgments section.

 

SUBMISSION:

Editor-in-Chief:

Professor Demosthenes Bouros, MD, FCCP

PNEUMON Journal, Hospital for Diseases of the Chest "SOTIRIA",

152 Messogeion Ave, 11527, Athens, GREECE

Tel./Fax: +30-210-7487723

http://www.hts.org.gr

E-mail: pneumon@hts.org.gr

 

Table1

Suggested Maximum Length Requirements for Submitted Manuscripts

(November 2008)

 

 

Type of publication

 

Abstract

(words)

Body of

Manuscript

(words)*

 

References

(number)

Editorial

n/a

1000

15

Original Research

250

3500

50

Reviews

250

4500

100

Case Reports

150

1500

20

Special Articles

250

2500

50

Correspondence

n/a

500

5

*excluding References, Tables, Acknowledgements and Figure Legends

n/a: not applicable

Manuscript Submission

You can submit your manuscript using the following online form.